2022
DOI: 10.1016/j.neucie.2021.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Neuromodulation of the anterior thalamic nucleus as a therapeutic option for difficult-to-control epilepsy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…In a rat model, high frequency electrical stimulation of 500 μA disturbed the acquisition of contextual fear and impaired spatial memory [ 140 ], while ATN unilateral stimulation modulated memory performance along with increased c-Fos expression in the rat model and DBS-ATN had a significant impact on the other structures which are far from the target [ 110 , 141 ]. Interestingly, the ATN stimulation mitigated epilepsy in various clinical [ [142] , [143] , [144] ] and preclinical [ 141 ] observations and currently DBS-ATN has been approved for the treatment of refractory epilepsy. ATN-DBS was associated with subjectively reported depression and memory deficits [ 140 ].…”
Section: Deep Brain Stimulation (Dbs) and Alzheimer's Diseasementioning
confidence: 99%
“…In a rat model, high frequency electrical stimulation of 500 μA disturbed the acquisition of contextual fear and impaired spatial memory [ 140 ], while ATN unilateral stimulation modulated memory performance along with increased c-Fos expression in the rat model and DBS-ATN had a significant impact on the other structures which are far from the target [ 110 , 141 ]. Interestingly, the ATN stimulation mitigated epilepsy in various clinical [ [142] , [143] , [144] ] and preclinical [ 141 ] observations and currently DBS-ATN has been approved for the treatment of refractory epilepsy. ATN-DBS was associated with subjectively reported depression and memory deficits [ 140 ].…”
Section: Deep Brain Stimulation (Dbs) and Alzheimer's Diseasementioning
confidence: 99%